Corporate News 20-Jan-22
Suven Pharmaceuticals director resigns
with effect from 19 January 2022
Suven Pharmaceuticals announced the resignation of Dr. Chandrasekhar Srivari (DIN: 00481481) from the post of non-executive independent director of the company with effect from 19 January 2022.
Previous News
Suven Pharmaceuticals to convene board meeting
( Corporate News - 27-Sep-24 10:46 )
Suven Pharmaceuticals appoints Vivek Sharma as new Executive Chairman
( Corporate News - 19-Sep-24 19:41 )
Board of Suven Pharmaceuticals approves change in Executive Chairperson
( Corporate News - 19-Sep-24 19:28 )
Garware Technical Fibres Ltd leads gainers in 'A' group
( Hot Pursuit - 19-Sep-24 12:00 )
Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter
( Results - Announcements 09-Aug-24 16:00 )
Suven Pharmaceuticals to hold board meeting
( Corporate News - 06-Aug-24 17:05 )
Volumes spurt at Torrent Power Ltd counter
( Hot Pursuit - 31-Jul-24 14:30 )
Volumes spurt at Torrent Power Ltd counter
( Hot Pursuit - 31-Jul-24 11:00 )
Suven Pharmaceuticals to conduct AGM
( Corporate News - 15-Jul-24 17:27 )
Suven Pharma soars after signing deal to acquire oligo drugs maker Sapala Organics
( Hot Pursuit - 14-Jun-24 12:21 )
Board of Suven Pharmaceuticals approves investment in a renewable entity
( Corporate News - 31-May-24 10:47 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
